SCHEMBL5497754

SCHEMBL5497754

[CH]1CN(c2ncccn2)CN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 3/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
CYP2D6 P10635 3/20 0.39
CYP3A4 P08684 2/20 0.39
TSHR P16473 2/20 0.39
POLB P06746 2/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP1A2 P05177 2/20 0.35
KMT2A Q03164 3/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7356574 0.79 ALDH1A1 (0.57) ALDH1A1KDM4EHSD17B10HPGDLMNA
SCHEMBL10498542 0.68 LMNA (0.70) ALDH1A1KDM4ELMNAMAPTCYP2D6
SCHEMBL6663539 0.68
SCHEMBL407831 0.65 ALDH1A1 (0.73) ALDH1A1KDM4EHSD17B10HPGDLMNA
SCHEMBL18228600 0.64 KDM4E (0.60) ALDH1A1KDM4EHSD17B10LMNAMAPT
SCHEMBL2168776 0.64 KDM4E (0.60) ALDH1A1KDM4EHSD17B10LMNAMAPT
SCHEMBL3339822 0.64 KDM4E (0.60) ALDH1A1KDM4EHSD17B10LMNAMAPT
SCHEMBL17925894 0.64 ALDH1A1 (0.44) ALDH1A1KDM4EHSD17B10HPGDLMNA
2-Piperazin-1-Yl-Pyrimidine SCHEMBL893739 0.64 ALDH1A1 (0.95) ALDH1A1KDM4EHSD17B10HPGDLMNA
2-Piperazin-1-Yl-Pyrimidine SCHEMBL169214 0.64 ALDH1A1 (0.95) ALDH1A1KDM4EHSD17B10HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1390056-A4 GLYCOPEPTIDE ANTIBIOTICS WYETH CORP (US) 2007-06-20 EP disclosed
EP-1390056-A2 GLYCOPEPTIDE ANTIBIOTICS Wyeth Holdings Corporation (US) 2004-02-25 EP disclosed
WO-2002085307-A2 GLYCOPEPTIDE ANTIBIOTICS WYETH HOLDINGS CORPORATION (US) 2002-10-31 WO disclosed